Abstract
Background
The temporality between the mandated reduction of salt in processed food and the decrease of death from stroke and ischemic heart disease, the association of hypertension, and cardiovascular disease led many public health organizations to recommend reducing dietary sodium to a maximum of 2300 mg per day. It turns out that some nuances can be brought about to this universally shared belief.
Methods & Results
Indeed, consideration of health outcomes instead of only blood pressure as a surrogate marker of cardiovascular disease and prognosis gave contradictory results whereas low sodium intake is associated to an excess of death and cardiovascular events.
Conclusions
Accordingly, sodium intake should be adapted to individual risk factors, and evidence is still clearly lacking to support indiscriminate recommendations in healthy people. By contrast, a restricted sodium diet is certainly useful in patients with chronic kidney disease exposed to salt retention, and by reciprocity, low sodium diet must be absolutely avoided in all patients presenting renal or extra renal sodium wasting where sodium depletion is a life-threatening condition.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Sodium intake is doubly vital for mammals and human life. Indeed, the total amount of sodium in the system is determining the volume of the extracellular fluid (Fig. 1a) and the quality of organ perfusion [1, 2]. In addition, changes in the sodium potassium gradient between the extracellular and the intracellular fluids are also mandatory for the depolarizaton then the repolarization of all excitable cells, including neurons and cardiomyocytes [3]. Consistently, herbivorous domestic mammals need salt supplementation to be bred in good conditions [4] and herbivorous wild mammals have a natural avidity for salt and mineral sources [5]. In humans, who are also mammals, the mean sodium intake is 3.6 g/day, and for 90% of persons, the variability of sodium intake holds in a very short range from 3.1 to 4.4 g/day (meaning 8 to 11 g/day of table salt) [6]. Of note, the mean intake value of 3.6 g per day coincides with an inflection point at which lower intakes have been reported to elevate plasma renin activity [6]. Sodium appetite and subsequently sodium intake are closely regulated by neurons expressing angiotensin-2 and aldosterone receptors located in the third ventricle and can explain the worldwide range of spontaneous sodium intake [6]. Interestingly, this regulation can be influenced by the sodium intake while preference of sodium chloride-rich foods in adults coincides with infants’ exposure to salty foods. It implies that a change in adult behavior is accessible to early education [7].
Salt retention is associated to a steady expansion of the extracellular fluid and a subsequent hypertension [1], in order to maintain the homeostatic value of osmotic pressure to 294 mosmol/kg of water (Fig. 1b) [8]. In apes, the increase of daily salt intake in non-human primates over the natural level during 2 years progressively leads to hypertension although a full reversibility has been observed when the natural low sodium vegetarian diet was resumed [9]. In humans, hypertension has been clearly linked to several genes involved in the sodium balance and especially in the renal sodium reabsorption and its regulation [10]. For decades, the progression of chronic kidney disease and the development of cardiovascular damage as well as premature death have been closely associated to hypertension [11,12,13]. Patients with chronic kidney disease that are prone to develop salt retention consistently encounter a high risk of hypertension, and cardiovascular events while the prevalence of heart failure are proportional to sodium intake [12]. Those facts led to promote public health policies aiming to reduce the daily sodium intake through a better control of sodium content, especially in processed food [14]. It recently turned out that some nuances might be brought about to this universally shared belief. Indeed, consideration of health outcomes instead of only blood pressure as a surrogate marker of cardiovascular disease gave contradictory results in several observational studies among the general population [15,16,17,18,19,20].
Sodium balance
Every day, the balance of the extracellular fluid is challenged by uncontrolled intakes of sodium and water that are compensated by adapted urinary outputs. The total amount of sodium is tightly regulated in the kidney by the regulation of sodium reabsorption in the collecting duct (Fig. 1c). At steady state, the ultimate concentration of sodium in the final urine is controlled by the level of circulating aldosterone and angiotensin-2, itself fixed by the level of the blood pressure through the secretion of renin in the arteries of the juxtaglomerular apparatus [21]. In case of sodium depletion, the human kidneys are able to retain all the sodium that is filtrated every day due to a powerful reabsorption in the collecting duct that can, on demand, decrease the sodium concentration in the final urine down to a zero level [21, 22]. It suggests that humans are able to survive despite steadily sodium deprivation [23], but it does not mean that sodium deprivation is harmless. In healthy humans, a standard sodium intake is consequently balanced by the modulation of sodium reabsorption (Fig. 1c) that prevents any sodium retention. In case of a dramatic and massive load of sodium, the tension of the right atrium wall leads to the release of the atrial natriuretic factor (ANF). ANF triggers a profound natriuresis and diuresis by a series of concerted actions along the nephron, including stimulation of glomerular filtration and inhibition of net salt and water reabsorption in the cortical and inner medullary collecting ducts [24]. Last but not least, increments in water and sodium excretion in response to an increase in perfusion pressure in the renal artery have been recognized more than a century ago using a model of isolated perfused kidneys [25]. Altogether, those mechanisms allow preventing the dangerous effects of acute hypervolemia, such as life-threatening levels of hypertension and pulmonary edema. In addition to the tight renal regulation of the sodium balance, the storage of sodium in collagen, glycosaminoglycans, and some subsets of immune cells without proportional water retention allows to buffer sodium loads in excess whereas the volume of the extracellular fluid remains stable [26]. Consequently, in healthy people, a standard sodium diet does not necessarily mean sodium retention but salt sensitivity may vary among populations and many healthy people may show more hypertensive effect from sodium intake than others (Table 1) [27, 28].
Blood pressure and dietary sodium
A subset of 1499 patients originating in the addition of 1109 from the FLAMENGHO study (Flemish Study on Environment, Genes, and Health Outcomes, 1985–1990) to 390 from the EPOGH cohort (European Project on Genes in Hypertension, 1999–2001) had BP and sodium excretion measured at baseline and last follow-up (2005–2008) on a yearly basis [29]. Each 100-mmol increase in the sodium diet was associated to an increase of only 1.71 mmHg (+ 1.5% of the base level) of systolic blood pressure and no significant changes in diastolic blood pressure [29]. Although the study confirmed that a doubling of sodium intake was associated with a mild increase (2.2%) of systolic blood pressure, it failed to find a significant change in diastolic blood pressure despite the large size of the population. In addition, the longitudinal analysis of systolic blood pressure during 6 years showed a yearly increase of 0.37 mmHg for systolic blood pressure and 0.47 for diastolic blood pressure, whereas sodium excretion did not change or slightly decreased. Those results suggest that blood pressure and sodium intake might not be necessarily related on the long term, at least in a European population of mid age [29]. One should regret that the variability of salt sensitivity has not been assessed in this study.
A meta-analysis of 167 studies reciprocally showed that a low sodium diet led to a decrease in systolic and diastolic blood pressure whatever the initial level of blood pressure and the ethnicity [27]. Of note, the negative gain of blood pressure is homogeneous and moderate in normotensive individuals (Table 1), limited to less than 4% of the normal values of systolic and diastolic blood pressure [27]. By contrast, in hypertensive patients, the negative gain is variable according to ethnicities, low sodium diet being the most efficient on systolic blood pressure in Asians (− 10%) and Africans (− 6.5%) compared to Caucasian (− 5%) [27]. Altogether, those results indicate an increased salt sensitivity in hypertensive patients and a clear variability of salt sensitivity in normal individuals.
Epidemiological facts
The NHANES I study (National Health and Nutrition Examination Survey) gathering 11,346 individuals examined the linkage of sodium intake to morbidity and mortality [15]. The population of the study was shared in four quartiles according to the level of sodium intake based on a nutrition investigation by a 24-h recall. Although less reliable than 24-h urine sodium excretion to assess sodium intake, the level of blood pressure was identical whatever the level of the sodium intake. Unexpectedly, the death rate was lower in the highest quartile compared to the lowest quartile of sodium intake suggesting that harm may outweigh the supposed benefits of a low sodium diet [15]. However, people in quartiles were not equal in terms of initial morbidity: a history of either cardiovascular disease or hypertension was more prevalent in the lower quartile of sodium intake compared to the upper quartile. However, authors mentioned that the results were similar in a sub-analysis restricted to participants with no reported history of CVD at baseline. Moreover, a work done in 2807 patients with diabetes type 1 confirmed that the progression to end-stage renal disease and the death rate was higher in the patients undergoing a very low sodium intake compared to others [30]. Indeed, a modelization of the relative hazard ratio according to the level of sodium intake showed a similar risk at 50 and 270 mmol/day [30].
The aforementioned European study [29], including people without history of cardiovascular disease and treated hypertension, was based on the measurement of the 24-h urinary sodium output considered as a surrogate for the daily sodium intake. While people in the highest tertile of sodium intake had a higher incidence of hypertension during the follow-up, they had the lowest rate of cardiovascular events and mortality [29]. The NHANES III study was also done on 8699 individuals without initial cardiovascular history. Sodium intake was assessed on a 24-h diet recall. It showed similar results in terms of cardiovascular death, confirming the unexpected harm of low sodium diet [16]. A refined analysis of this population showed that the protection from cardiovascular mortality was proportional to the potassium intake instead to be related with the sodium intake [31]. Consistently, higher sodium-potassium ratio hit the highest risk of cardiovascular mortality while addition of sodium to processed foods obviously contributed to this undesirable ratio. At last, the Worksite Hypertension Study found no significant association between 24-h urinary sodium excretion and cardiovascular outcomes in the range from 55 to 225 mmol/day of sodium (3.5 to 13 g/day of salt). By contrast, a significant association of low sodium diet to all-cause mortality was evidenced [32]. Altogether, these findings suggest that sodium may be less dangerous than expected and the relationship with cardiovascular mortality being doubtful. Indeed, consistently with a U-shaped association between sodium intake and health outcomes, a range from 2.645 to 4.945 g/day of sodium has been associated with the most favorable health outcomes, within which a variation in sodium intake is not associated with variation in mortality [33]. It turns out that this range is somehow the mean spontaneous intake of 90% of people worldwide [22].
Animal experiments
Rats undergoing an extremely low salt diet (equivalent to less than 100 mg/day of Na Cl in humans) develop left ventricular hypertrophy and increased interventricular septal thickness while shortening fraction of the left ventricule remains unchanged [34]. Heart fibrosis and increased myocyte diameter were evidenced at the histological level. Those damages of the heart were consistently associated to the activation of plasma renin-angiotensin-aldosterone, sympatho-adrenal systems and activation of cardiac prorenin as well as angiotensin-2 AT1 receptor and their downstream signals [34]. Noteworthy, high sodium intake suppresses aldosterone and angiotensin-2 pathways through the activation of the nitric oxide synthase within the collecting duct leading to a down-expression of the epithelium sodium channel (ENaC) and the sodium pump [35]. In addition, the high sodium diet also leads to a down expression of ENaC in endothelial cells favoring vasodilation [36]. One should recall at this stage that longevity associated variants (DNA polymorphisms associated to individual surviving to the one percentile of age) include genes involved in the regulation of endothelial NO synthase [37]. One should remind that biological systems remain complex realities that cannot be analyzed according to one single concept.
The salt debate
The 2011 AHA (American heart Association) presidential advisory on sodium reduction recommends a sodium intake below 2300 mg/day (5.8 g/day of NaCl) in the general population and below 1500 mg (3.8 g/day of NaCl) in African Americans, healthy individuals over 51 years of age and patients with hypertension, diabetes, and chronic kidney disease [38]. The list of AHA arguments effectively deserves consideration: a lack of causal evidence between low sodium diet and increase mortality, methodological flaws in estimating sodium intake resulting in inconsistency of results relating the reduction of sodium intake and cardiovascular mortality, the temporality between the legally enforced reduction of salt in processed food and the decrease of death from stroke and ischemic heart disease in the United Kingdom, the strong association of hypertension with the risk of cardiovascular disease [38,39,40]. On the other hand, several “sodium dissident” authors deny the sodium reduction health policy in the US on another list of arguments that also deserve consideration: data from basic science on the activation of the renin-angiotensin system, the threshold of sodium intake that activates the renin angiotensin system, the universality of the spontaneous level of sodium intake in general populations, and measures of global health outcomes according to the level of sodium intake [17, 19, 20, 41]. The main issue of controversy is the method to measure sodium intake while 24-h diet recall and estimation of the 24-h urinary sodium excretion on a morning sample of urine are directly accused of significant bias [39, 42]. Randomized control trials on long lasting period of time come up against the poor adherence to sodium diet and individual “random” behavior changes during the time of the study. While adherence to 1800 to 2300 mg/day level of sodium has proven difficult in a general population with free access to any food, a group gathering “orthodox and dissident” authors arrived at a consensus that a clinical trial in a prison population (particularly federal prisons in the USA) might provide the best setting to conduct the trial [43]. According to authors themselves, many issues have to be considered before moving forward in this direction.
Conclusion
Humans like all living beings are not created equal and sodium intake should be adapted to individual risk factors. There is nothing obvious to support a general rule applying for the general population and a sodium intake in the spontaneous range might not be harmful in most people. Consequently, evidence is still clearly lacking to support indiscriminate recommendations in healthy people. By contrast, a restricted sodium diet is certainly useful in patients with chronic kidney disease exposed to salt retention while obviously by reciprocity, low sodium diet has to be avoided in all patients presenting renal or extra renal sodium wasting where sodium depletion may be life-threatening.
References
Guyton AC (1990) Long-term arterial pressure control: an analysis from animal experiments and computer and graphic models. Am J Phys 259:R865–R877
Kaltreider NL, Meneely GR, Allen JR, Bale WF (1941) Determination of the volume of the extracellular fluid of the body with radioactive sodium. J Exp Med 74:569–590
Hodgkin AL, Huxley AF (1952) Movement of sodium and potassium ions during nervous activity. Cold Spring Harb Symp Quant Biol 17:43–52
Haenlein G (1980) Mineral nutrition in goats. J Dairy Sci 63:1729–1748
Rothman JM, Van Soest PJ, Pell AN (2006) Decaying wood is a sodium source for mountain gorillas. Biol Lett 2:321–324
Lowell BB (2019) New neuroscience of homeostasis and drives for food, water, and salt. N Engl J Med 380:459–471
Liem DG (2017) Infants’ and Children’s salt taste perception and liking: a review. Nutrients 9:e1011
Cheuvront SN, Kenefick RW, Heavens KR, Spitz MG (2014) A comparison of whole blood and plasma osmolality and osmolarity. J Clin Lab Anal 28:368–373
Denton D, Weisinger R, Mundy NI, Wickings EJ, Dixson A, Moisson P, Pingard AM, Shade R, Carey D, Ardaillou R et al (1995) The effect of increased salt intake on blood pressure of chimpanzees. Nat Med 1:1009–1016
Ng FL, Warren HR, Caulfield MJ (2018) Hypertension genomics and cardiovascular prevention. Ann Transl Med 6:291
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360:1903–1913
Mills KT, Chen J, Yang W, Appel LJ, Kusek JW, Alper A, Delafontaine P, Keane MG, Mohler E, Ojo A, Rahman M, Ricardo AC, Soliman EZ, Steigerwalt S, Townsend R, He J (2016) Sodium excretion and the risk of cardiovascular disease in patients with chronic kidney disease. JAMA 315:2200–2210
Pohl MA, Blumenthal S, Cordonnier DJ, De Alvaro F, Deferrari G, Eisner G, Esmatjes E, Gilbert RE, Hunsicker LG, de Faria JB, Mangili R, Moore J Jr, Reisin E, Ritz E, Schernthaner G, Spitalewitz S, Tindall H, Rodby RA, Lewis EJ (2005) Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations. J Am Soc Nephrol 16:3027–3037
Cogswell ME, Mugavero K, Bowman BA, Frieden TR (2016) Dietary sodium and cardiovascular disease risk--measurement matters. N Engl J Med 375:580–586
Alderman MH, Cohen H, Madhavan S (1998) Dietary sodium intake and mortality: the National Health and nutrition examination survey (NHANES I). Lancet 351:781–785
Cohen HW, Hailpern SM, Alderman MH (2008) Sodium intake and mortality follow-up in the third National Health and nutrition examination survey (NHANES III). J Gen Intern Med 23:1297–1302
Graudal N, Jurgens G (2018) Conflicting evidence on health effects associated with salt reduction calls for a redesign of the salt dietary guidelines. Prog Cardiovasc Dis 61:20–26
O'Donnell M, Mente A, Rangarajan S, McQueen MJ, O'Leary N, Yin L, Liu X, Swaminathan S, Khatib R, Rosengren A, Ferguson J, Smyth A, Lopez-Jaramillo P, Diaz R, Avezum A, Lanas F, Ismail N, Yusoff K, Dans A, Iqbal R, Szuba A, Mohammadifard N, Oguz A, Yusufali AH, Alhabib KF, Kruger IM, Yusuf R, Chifamba J, Yeates K, Dagenais G, Wielgosz A, Lear SA, Teo K, Yusuf S (2019) Joint association of urinary sodium and potassium excretion with cardiovascular events and mortality: prospective cohort study. BMJ 364:l772
O'Donnell M, Mente A, Yusuf S (2018) Response to: 'More on dissidents and dietary sodium'. Int J Epidemiol 47:673–674
Stolarz-Skrzypek K, Staessen JA (2015) Reducing salt intake for prevention of cardiovascular disease--times are changing. Adv Chronic Kidney Dis 22:108–115
Feraille E, Doucet A (2001) Sodium-potassium-adenosinetriphosphatase-dependent sodium transport in the kidney: hormonal control. Physiol Rev 81:345–418
McCarron DA (2014) What determines human sodium intake: policy or physiology? Adv Nutr 5:578–584
Oliver WJ, Cohen EL, Neel JV (1975) Blood pressure, sodium intake, and sodium related hormones in the Yanomamo Indians, a "no-salt" culture. Circulation 52:146–151
Zeidel ML (1990) Renal actions of atrial natriuretic peptide: regulation of collecting duct sodium and water transport. Annu Rev Physiol 52:747–759
Girardin E, Caverzasio J, Iwai J, Bonjour JP, Muller AF, Grandchamp A (1980) Pressure natriuresis in isolated kidneys from hypertension-prone and hypertension-resistant rats (dahl rats). Kidney Int 18:10–19
Wiig H, Luft FC, Titze JM (2018) The interstitium conducts extrarenal storage of sodium and represents a third compartment essential for extracellular volume and blood pressure homeostasis. Acta Physiol (Oxford) 222:e13006
Graudal NA, Hubeck-Graudal T, Jurgens G (2012) Effects of low-sodium diet vs. high-sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride (Cochrane review). Am J Hypertens 25:1–15
Weaver CM, Bailey RL, McCabe LD, Moshfegh AJ, Rhodes DG, Goldman JD, Lobene AJ, McCabe GP (2018) Mineral intake ratios are a weak but significant factor in blood pressure variability in US adults. J Nutr 148:1845–1851
Stolarz-Skrzypek K, Kuznetsova T, Thijs L, Tikhonoff V, Seidlerova J, Richart T, Jin Y, Olszanecka A, Malyutina S, Casiglia E, Filipovsky J, Kawecka-Jaszcz K, Nikitin Y, Staessen JA (2011) Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA 305:1777–1785
Thomas MC, Moran J, Forsblom C, Harjutsalo V, Thorn L, Ahola A, Waden J, Tolonen N, Saraheimo M, Gordin D, Groop PH (2011) The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care 34:861–866
Yang Q, Liu T, Kuklina EV, Flanders WD, Hong Y, Gillespie C, Chang MH, Gwinn M, Dowling N, Khoury MJ, Hu FB (2011) Sodium and potassium intake and mortality among US adults: prospective data from the third National Health and nutrition examination survey. Arch Intern Med 171:1183–1191
Singer P, Cohen H, Alderman M (2015) Assessing the associations of sodium intake with long-term all-cause and cardiovascular mortality in a hypertensive cohort. Am J Hypertens 28:335–342
Graudal N, Jurgens G, Baslund B, Alderman MH (2014) Compared with usual sodium intake, low- and excessive-sodium diets are associated with increased mortality: a meta-analysis. Am J Hypertens 27:1129–1137
Okamoto C, Hayakawa Y, Aoyama T, Komaki H, Minatoguchi S, Iwasa M, Yamada Y, Kanamori H, Kawasaki M, Nishigaki K, Mikami A (2017) Excessively low salt diet damages the heart through activation of cardiac (pro) renin receptor, renin-angiotensin-aldosterone, and sympatho-adrenal systems in spontaneously hypertensive rats. PLoS One 12:e0189099
Hyndman KA, Mironova EV, Giani JF, Dugas C, Collins J, McDonough AA, Stockand JD, Pollock JS (2017) Collecting duct nitric oxide synthase 1ss activation maintains sodium homeostasis during high sodium intake through suppression of aldosterone and renal angiotensin II pathways. J Am Heart Assoc 6:e006896
Liu HB, Zhang J, Sun YY, Li XY, Jiang S, Liu MY, Shi J, Song BL, Zhao D, Ma HP, Zhang ZR (2015) Dietary salt regulates epithelial sodium channels in rat endothelial cells: adaptation of vasculature to salt. Br J Pharmacol 172:5634–5646
Spinelli CC, Carrizzo A, Ferrario A, Villa F, Damato A, Ambrosio M, Madonna M, Frati G, Fucile S, Sciaccaluga M, Capunzo M, Cali G, Milanesi L, Maciag A, Puca AA, Vecchione C (2017) LAV-BPIFB4 isoform modulates eNOS signalling through Ca2+/PKC-alpha-dependent mechanism. Cardiovasc Res 113:795–804
Appel LJ, Frohlich ED, Hall JE, Pearson TA, Sacco RL, Seals DR, Sacks FM, Smith SC Jr, Vafiadis DK, Van Horn LV (2011) The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association. Circulation 123:1138–1143
Capuccio F, Beer M, Strazzullo P, Network oESA (2019) Population dietary salt reduction and the risk of cardiovascular disease. A scientific statement from the European salt action Network. Nutr Metab Cardiovasc Dis 29:107–114
Cobb LK, Anderson CA, Elliott P, Hu FB, Liu K, Neaton JD, Whelton PK, Woodward M, Appel LJ (2014) Methodological issues in cohort studies that relate sodium intake to cardiovascular disease outcomes: a science advisory from the American Heart Association. Circulation 129:1173–1186
McCarron DA, Geerling JC, Alderman MH (2019) Urinary sodium excretion measures and health outcomes. Lancet 393:1294–1295
Wen X, Zhou L, Stamler J, Chan Q, Van Horn L, Daviglus ML, Dyer AR, Elliott P, Ueshima H, Miura K, Okuda N, Wu Y, Zhao L (2019) Agreement between 24-h dietary recalls and 24-h urine collections for estimating sodium intake in China, Japan, UK, USA: the international study of macro- and micro-nutrients and blood pressure. J Hypertens 37:814–819
Jones DW, Luft FC, Whelton PK, Alderman MH, Hall JE, Peterson ED, Califf RM, McCarron DA (2018) Can we end the salt wars with a randomized clinical trial in a controlled environment? Hypertension 72:10–11
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Deschênes, G. Sodium—not harmful?. Pediatr Nephrol 35, 1771–1776 (2020). https://doi.org/10.1007/s00467-019-04356-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-019-04356-x